Cargando…
REG Iα is a biomarker for predicting response to chemotherapy with S-1 plus cisplatin in patients with unresectable stage IV gastric cancer
BACKGROUND: The regenerating gene Iα (REG Iα) is involved in gastric carcinogenesis as an antiapoptotic factor. Therefore, we investigated whether REG Iα confers resistance to chemotherapeutic drugs in gastric cancer (GC) cells and whether REG Iα expression is useful for predicting the response to c...
Autores principales: | Sekikawa, A, Fukui, H, Zhang, X, Maruo, T, Tsumura, T, Okabe, Y, Wakasa, T, Osaki, Y, Chiba, T, Tomita, T, Oshima, T, Watari, J, Miwa, H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3566803/ https://www.ncbi.nlm.nih.gov/pubmed/23322208 http://dx.doi.org/10.1038/bjc.2012.572 |
Ejemplares similares
-
IL-22 produced by cancer-associated fibroblasts promotes gastric cancer cell invasion via STAT3 and ERK signaling
por: Fukui, H, et al.
Publicado: (2014) -
Expression of SDF-1α and nuclear CXCR4 predicts lymph node metastasis in colorectal cancer
por: Yoshitake, N, et al.
Publicado: (2008) -
The Link between Type III Reg and STAT3-Associated Cytokines in Inflamed Colonic Tissues
por: Xu, Xin, et al.
Publicado: (2019) -
CYP2A6 and ERCC1 polymorphisms correlate with efficacy of S-1 plus cisplatin in metastatic gastric cancer patients
por: Park, S R, et al.
Publicado: (2011) -
A Case of Myelodysplastic Syndrome with Intestinal Behçet’s Disease-Like Symptoms Treated by Prednisolone and Azacitidine
por: Endo, Masatsugu, et al.
Publicado: (2015)